VIRUSES, SCHIZOPHRENIA, AND BIPOLAR DISORDER

被引:287
|
作者
YOLKEN, RH
TORREY, EF
机构
关键词
D O I
10.1128/CMR.8.1.131
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The hypothesis that viruses or other infectious agents may cause schizophrenia or bipolar disorder dates to the 19th century but has recently been revived. It could explain many clinical genetic, and epidemiologic aspects of these diseases, including the winter-spring birth seasonality, regional differences, urban birth, household crowding, having an older sibling, and prenatal exposure to influenza as risk factors. It could also explain observed immunological changes such as abnormalities of lymphocytes, proteins, autoantibodies, and cytokines. However, direct studies of viral infections in individuals with these psychiatric diseases have been predominantly negative. Most studies have examined antibodies in blood or cerebrospinal fluid and relatively few studies have been done on viral antigens, genomes, cytopathic effect on cell culture, and animal transmission experiments. Viral research on schizophrenia and bipolar disorder is thus comparable to viral research on multiple sclerosis and Parkinson's disease: an attractive hypothesis with scattered interesting findings but no clear proof. The application of molecular biological techniques may allow the identification of novel infectious agents and the associations of these novel agents with serious mental diseases.
引用
收藏
页码:131 / 145
页数:15
相关论文
共 50 条
  • [31] Nosology and genetics of schizophrenia and bipolar disorder
    Rietschel, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 34 - 34
  • [32] The microbiome, immunity, and schizophrenia and bipolar disorder
    Dickerson, Faith
    Severance, Emily
    Yolken, Robert
    BRAIN BEHAVIOR AND IMMUNITY, 2017, 62 : 46 - 52
  • [33] Oligodendrocyte dysfunction in schizophrenia and bipolar disorder
    Tkachev, D
    Mimmack, ML
    Ryan, MM
    Wayland, M
    Freeman, T
    Jones, PB
    Starkey, M
    Webster, MJ
    Yolken, RH
    Bahn, S
    LANCET, 2003, 362 (9386): : 798 - 805
  • [34] SCHIZOPHRENIA AND BIPOLAR DISORDER - OPPOSITES OR CONTINUUM
    VERDOUX, H
    BOURGEOIS, M
    ANNALES MEDICO-PSYCHOLOGIQUES, 1994, 152 (01): : 75 - 78
  • [35] The kynurenine pathway in schizophrenia and bipolar disorder
    Erhardt, Sophie
    Schwieler, Lilly
    Imbeault, Sophie
    Engberg, Goran
    NEUROPHARMACOLOGY, 2017, 112 : 297 - 306
  • [36] Dermatoglyphics: A comparison of schizophrenia and bipolar disorder
    McTigue, O
    Clarke, M
    Gervin, M
    Kamali, M
    Browne, S
    Whitty, P
    Kinsella, A
    Lane, A
    Larkin, C
    O'Callaghan, E
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 45 - 45
  • [37] Hippocampal function in schizophrenia and bipolar disorder
    Hall, J.
    Whalley, H. C.
    Marwick, K.
    McKirdy, J.
    Sussmann, J.
    Romaniuk, L.
    Johnstone, E. C.
    Wan, H. I.
    McIntosh, A. M.
    Lawrie, S. M.
    PSYCHOLOGICAL MEDICINE, 2010, 40 (05) : 761 - 770
  • [38] Electrophysiological measures in schizophrenia and bipolar disorder
    Domjan, N.
    Csifcsak, G.
    Szendi, I.
    Janka, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S509 - S510
  • [39] Bipolar Disorder, Schizophrenia, and Metabolic Syndrome
    Bartoli, Francesco
    Carra, Giuseppe
    Crocamo, Cristina
    Carretta, Daniele
    Clerici, Massimo
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (08): : 927 - 928
  • [40] Cognitive deficits in schizophrenia and bipolar disorder
    Vieta, E
    Daban, C
    Martinez-Aran, A
    EUROPEAN PSYCHIATRY, 2005, 20 : S49 - S50